A recent study led by MedUni Vienna provides new insights into the mechanisms of coagulation in people with hemophilia A, the ...

A recent study led by MedUni Vienna provides new insights into the mechanisms of coagulation in persons with haemophilia A, the most common form of haemophilia. The research team was able to show that ...

A recent study provides new insights into the mechanisms of coagulation in persons with haemophilia A, the most common form of haemophilia. The research team was able to show that saliva contains ...

A recent study led by MedUni Vienna provides new insights into the mechanisms of coagulation in persons with haemophilia A, the most common form of ...

Hemophilia B causes a deficiency in factor ... The infusion of factor IX back into the body rebalances the clotting cascade for a certain period of time. Two types of recombinant factor IX are ...

Instead of providing a version of FVIII, it mimics the activity of the protein in the blood clotting cascade. The therapy is approved in the U.S. for hemophilia A patients with or without inhibitors, ...

UC San Diego Health one of a few health care systems on West Coast to offer new gene therapy for hemophilia B.

(Photo courtesy of @UCSDHealth via Facebook) Hemophilia B is a rare, inherited bleeding disorder that prevents blood from clotting properly and puts those who suffer from it in grave danger of ...

The aim is to allow his body to produce enough of the blood clotting factor it can’t make now to reduce his need to infuse it. Stevens, 63, suffers from hemophilia B, a bleeding disorder caused ...

After more than four decades of infusing himself with the blood clotting factor his body can’t make, Chad Stevens decided it was time to try something new. Stevens, 63, suffers from hemophilia B ...